Expert Opinion on Drug Metabolism & Toxicology, Volume 15, Issue 9 (2019)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 15, Issue 9 (2019)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Volume 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Aspirin killed the cat: animal research models do not always apply to humans
Jennifer Bell
Pages: 683-685
Published online: 05 Aug 2019
First Page PreviewforAspirin killed the cat: animal research models do not always apply to humans | Full Text | References | PDF (466.5 KB) | EPUB
  • 239 Views
  • 2 CrossRef citations
  • 0Altmetric

Original Research

Article
S-amlodipine–bisoprolol combination therapy caused elevated transaminases and triglyceride levels in healthy Chinese subjects: a randomized controlled, open-label, multiple-dose pharmacokinetic interaction study
Jingrui Liu, Xiaojiao Li, Hong Zhang, Yusi Liu, Min Wu, Junqi Niu & Yanhua Ding
Pages: 687-695
Published online: 07 Aug 2019
AbstractforS-amlodipine–bisoprolol combination therapy caused elevated transaminases and triglyceride levels in healthy Chinese subjects: a randomized controlled, open-label, multiple-dose pharmacokinetic interaction study | Full Text | References | PDF (1.5 MB) | EPUB
  • 262 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
Simone Garzon, Antonio Simone Laganà & Giovanni Monastra
Pages: 697-703
Published online: 08 Aug 2019
AbstractforRisk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 182 Views
  • 17 CrossRef citations
  • 0Altmetric

Review

Article
Is curcumin bioavailability a problem in humans: lessons from clinical trials
Ajaikumar B. Kunnumakkara, Choudhary Harsha, Kishore Banik, Rajesh Vikkurthi, Bethsebie L. Sailo, Devivasha Bordoloi, Subash C. Gupta & Bharat B. Aggarwal
Pages: 705-733
Published online: 29 Aug 2019
AbstractforIs curcumin bioavailability a problem in humans: lessons from clinical trials | Full Text | References | PDF (2.8 MB) | EPUB
  • 1053 Views
  • 133 CrossRef citations
  • 0Altmetric
Article
Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle
Karel Allegaert, Robert Flint & Anne Smits
Pages: 735-749
Published online: 19 Aug 2019
AbstractforPharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle | Full Text | References | PDF (1.7 MB) | EPUB
  • 541 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline
Giuseppe Miscio, Giulia Paroni, Paola Bisceglia, Carolina Gravina, Maria Urbano, Madia Lozupone, Carla Piccininni, Michele Prisciandaro, Grazia Ciavarella, Antonio Daniele, Antonello Bellomo, Francesco Panza, Lazzaro Di Mauro, Antonio Greco & Davide Seripa
Pages: 751-765
Published online: 12 Sep 2019
AbstractforPharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline | Full Text | References | PDF (1.5 MB) | EPUB
  • 234 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Molecular basis for class side effects associated with PI3K/AKT/mTOR pathway inhibitors
Ying Zhang, Hao Yan, Zhifei Xu, Bo Yang, Peihua Luo & Qiaojun He
Pages: 767-774
Published online: 03 Sep 2019
AbstractforMolecular basis for class side effects associated with PI3K/AKT/mTOR pathway inhibitors | Full Text | References | PDF (679.7 KB) | EPUB
  • 1167 Views
  • 50 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Nguyen Quoc Khanh Le et al.
Review Article | Published online: 27 May 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperoni et al.
Review Article | Published online: 22 May 2024
Open Access
The role of the circadian timing system on drug metabolism and detoxification: an update
Alper Okyar et al.
Review Article | Published online: 20 May 2024
Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer’s
Tanya Song et al.
Review Article | Published online: 20 May 2024
View all latest articles